Opinions on mandating hpv vaccine

Rated 4.81/5 based on 782 customer reviews

A large body of evidence supports the safety and efficacy of the vaccine, and several studies have found that getting the shots does not lead to kids engaging in more risky sexual behavior.“That’s been pretty persuasively put to bed,” Schwartz said.Factors affecting uptake of the vaccine were examined at different levels of the socio-ecological model (policy, community, organisational, interpersonal and intrapersonal). Whether young women receive the HPV vaccine is strongly governed by the decisions of policy makers, healthcare professionals, and parents.These decisions are shaped by: financial considerations; social norms and values relating to sexual activity, and; trust in vaccination programmes and healthcare providers.This test has high specificity, but low sensitivity and so erroneous results are not uncommon [].Furthermore, not all women worldwide have had access to the test – especially in developing countries, but also in developed countries – so it has not been effective at a global level.This paper reflects on the ethical legitimacy of the universal vaccination of girls and young women against HPV infection, especially regarding safety issues, the need to vaccinate people who have opted to abstain from sex, the presumption of early onset of sexual relations, the commercial interests of the companies that manufacture the vaccine, and the recommendation of universal vaccination in males.Human papilloma virus (HPV) is routinely found in humans.

opinions on mandating hpv vaccine-28

opinions on mandating hpv vaccine-77

In addition, HPV infection is also responsible for other types of cancer in women, such as vaginal and vulvar cancer, and also for certain cancers in males, such as oropharyngeal, penile, and anal canal cancer; [ The most effective measure for preventing cervical cancer in the last century was the introduction of cervical screening programmes, especially the Papanicolaou test, for the early detection of precancerous lesions in women that were already infected (secondary prevention).

Financial constraints may be overcome through universal healthcare systems offering the HPV vaccine free at the point of delivery.

In the healthcare setting, judgements by healthcare professionals about whether to recommend the vaccine may restrict a young woman’s access to the vaccine irrespective of her own beliefs and preferences.

The number of parents "opting out" of vaccination altogether for their children is increasing in many places.

Rushing the HPV vaccination onto the mandated list into that environment could easily result in more parents opting out of vaccination altogether at earlier ages in anticipation of the HPV vaccine.

Leave a Reply